Alan S Forman - Net Worth and Insider Trading
Alan S Forman Net Worth
The estimated net worth of Alan S Forman is at least $1 Million dollars as of 2024-11-08. Alan S Forman is the Director of Stemline Therapeutics Inc and owns about 88,298 shares of Stemline Therapeutics Inc (STML) stock worth over $1 Million. Alan S Forman is also the Director of JBG SMITH Properties and owns about 5,000 shares of JBG SMITH Properties (JBGS) stock worth over $86,250. Details can be seen in Alan S Forman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan S Forman has not made any transactions after 2022-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan S Forman
Alan S Forman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan S Forman owns 3 companies in total, including Stemline Therapeutics Inc (STML) , JBG SMITH Properties (JBGS) , and Acadia Realty Trust (AKR) .
Click here to see the complete history of Alan S Forman’s form 4 insider trades.
Insider Ownership Summary of Alan S Forman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
STML | Stemline Therapeutics Inc | 2020-06-10 | director |
JBGS | JBG SMITH Properties | 2022-05-10 | director |
AKR | Acadia Realty Trust | 2005-05-18 | director |
Alan S Forman Latest Holdings Summary
Alan S Forman currently owns a total of 2 stocks. Among these stocks, Alan S Forman owns 88,298 shares of Stemline Therapeutics Inc (STML) as of December 4, 2019, with a value of $1 Million and a weighting of 92.37%. Alan S Forman also owns 5,000 shares of JBG SMITH Properties (JBGS) as of May 10, 2022, with a value of $86,250 and a weighting of 7.63%.
Latest Holdings of Alan S Forman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
STML | Stemline Therapeutics Inc | 2019-12-04 | 88,298 | 11.83 | 1,044,565 |
JBGS | JBG SMITH Properties | 2022-05-10 | 5,000 | 17.25 | 86,250 |
Holding Weightings of Alan S Forman
Alan S Forman Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan S Forman has made a total of 2 transactions in Stemline Therapeutics Inc (STML) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Stemline Therapeutics Inc is the acquisition of 1,000 shares on December 4, 2019, which cost Alan S Forman around $9,730.
According to the SEC Form 4 filings, Alan S Forman has made a total of 1 transactions in JBG SMITH Properties (JBGS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in JBG SMITH Properties is the acquisition of 5,000 shares on May 10, 2022, which cost Alan S Forman around $121,600.
Insider Trading History of Alan S Forman
- 1
Alan S Forman Trading Performance
GuruFocus tracks the stock performance after each of Alan S Forman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan S Forman is -25.94%. GuruFocus also compares Alan S Forman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan S Forman within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan S Forman's insider trading performs compared to the benchmark.
Performance of Alan S Forman
Alan S Forman Ownership Network
Ownership Network List of Alan S Forman
Ownership Network Relation of Alan S Forman
Alan S Forman Owned Company Details
What does Stemline Therapeutics Inc do?
Who are the key executives at Stemline Therapeutics Inc?
Alan S Forman is the director of Stemline Therapeutics Inc. Other key executives at Stemline Therapeutics Inc include Chief Operating Officer Kenneth Hoberman , and Chief Medical Officer Eric K Rowinsky .
Stemline Therapeutics Inc (STML) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Stemline Therapeutics Inc (STML) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Stemline Therapeutics Inc (STML) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Stemline Therapeutics Inc (STML)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stemline Therapeutics Inc Insider Transactions
Alan S Forman Mailing Address
Above is the net worth, insider trading, and ownership report for Alan S Forman. You might contact Alan S Forman via mailing address: 55 Whitney Avenue, 5th Floor, New Haven Ct 06511.